Vanguard Group Inc Collegium Pharmaceutical, Inc Transaction History

Vanguard Group Inc

  • $5.97 Trillion
  • Q2 2025

A detailed history of Vanguard Group Inc transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Vanguard Group Inc holds 2,248,211 shares of COLL stock, worth $77.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,248,211
Previous 2,246,568 0.07%
Holding current value
$77.1 Million
Previous $67.1 Million 0.87%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 11, 2025
BUY
$24.67 - $30.44 $40,532 - $50,012
1,643 Added 0.07%
2,248,211 $66.5 Million
Q1 2025

May 09, 2025
SELL
$28.04 - $33.91 $1.01 Million - $1.22 Million
-36,098 Reduced 1.58%
2,246,568 $67.1 Million
Q4 2024

Feb 11, 2025
SELL
$28.61 - $41.86 $1.83 Million - $2.67 Million
-63,876 Reduced 2.72%
2,282,666 $65.4 Million
Q3 2024

Nov 13, 2024
SELL
$31.4 - $39.07 $766,160 - $953,308
-24,400 Reduced 1.03%
2,346,542 $90.7 Million
Q2 2024

Aug 13, 2024
BUY
$31.36 - $39.99 $1.26 Million - $1.61 Million
40,214 Added 1.73%
2,370,942 $76.3 Million
Q1 2024

May 10, 2024
BUY
$31.23 - $40.91 $560,328 - $734,007
17,942 Added 0.78%
2,330,728 $90.5 Million
Q4 2023

Feb 14, 2024
SELL
$21.16 - $30.8 $556,719 - $810,348
-26,310 Reduced 1.12%
2,312,786 $71.2 Million
Q3 2023

Nov 14, 2023
BUY
$21.23 - $24.28 $49,656 - $56,790
2,339 Added 0.1%
2,339,096 $52.3 Million
Q2 2023

Aug 14, 2023
BUY
$21.06 - $24.0 $649,006 - $739,608
30,817 Added 1.34%
2,336,757 $50.2 Million
Q1 2023

May 15, 2023
BUY
$23.0 - $29.88 $2.25 Million - $2.92 Million
97,829 Added 4.43%
2,305,940 $55.3 Million
Q4 2022

Feb 10, 2023
SELL
$16.14 - $23.55 $1.49 Million - $2.17 Million
-92,076 Reduced 4.0%
2,208,111 $51.2 Million
Q3 2022

Nov 14, 2022
BUY
$15.46 - $20.1 $398,883 - $518,600
25,801 Added 1.13%
2,300,187 $36.8 Million
Q2 2022

Aug 12, 2022
SELL
$14.22 - $20.88 $457,073 - $671,145
-32,143 Reduced 1.39%
2,274,386 $40.3 Million
Q1 2022

May 13, 2022
BUY
$17.2 - $22.5 $328,726 - $430,020
19,112 Added 0.84%
2,306,529 $47 Million
Q4 2021

Feb 14, 2022
SELL
$17.5 - $21.35 $998,637 - $1.22 Million
-57,065 Reduced 2.43%
2,287,417 $42.7 Million
Q3 2021

Nov 12, 2021
BUY
$17.75 - $25.39 $1.85 Million - $2.64 Million
104,093 Added 4.65%
2,344,482 $46.3 Million
Q2 2021

Aug 13, 2021
BUY
$21.74 - $25.28 $48.7 Million - $56.6 Million
2,240,389 New
2,240,389 $53 Million

Others Institutions Holding COLL

# of Institutions
241
Shares Held
36.4M
Call Options Held
52.5K
Put Options Held
200
View Full List

About COLLEGIUM PHARMACEUTICAL, INC

COLL Quotes by TradingView
  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.17B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email